BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18022867)

  • 1. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.
    Schmechel S; Konrad A; Diegelmann J; Glas J; Wetzke M; Paschos E; Lohse P; Göke B; Brand S
    Inflamm Bowel Dis; 2008 Feb; 14(2):204-12. PubMed ID: 18022867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
    Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Chrousos G; Anagnou NP; Roma-Giannikou E
    World J Gastroenterol; 2010 Apr; 16(14):1753-8. PubMed ID: 20380008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
    Stallhofer J; Friedrich M; Konrad-Zerna A; Wetzke M; Lohse P; Glas J; Tillack-Schreiber C; Schnitzler F; Beigel F; Brand S
    Inflamm Bowel Dis; 2015 Oct; 21(10):2327-40. PubMed ID: 26263469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population.
    Baptista ML; Amarante H; Picheth G; Sdepanian VL; Peterson N; Babasukumar U; Lima HC; Kugathasan S
    Inflamm Bowel Dis; 2008 May; 14(5):674-9. PubMed ID: 18200510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
    Diegelmann J; Czamara D; Le Bras E; Zimmermann E; Olszak T; Bedynek A; Göke B; Franke A; Glas J; Brand S
    PLoS One; 2013; 8(11):e77773. PubMed ID: 24223725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
    Glas J; Seiderer J; Bayrle C; Wetzke M; Fries C; Tillack C; Olszak T; Beigel F; Steib C; Friedrich M; Diegelmann J; Czamara D; Brand S
    PLoS One; 2011; 6(12):e29309. PubMed ID: 22242114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
    Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR
    J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
    Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
    Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
    Roberts RL; Gearry RB; Hollis-Moffatt JE; Miller AL; Reid J; Abkevich V; Timms KM; Gutin A; Lanchbury JS; Merriman TR; Barclay ML; Kennedy MA
    Am J Gastroenterol; 2007 Dec; 102(12):2754-61. PubMed ID: 17894849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children.
    Amre DK; Mack D; Israel D; Morgan K; Lambrette P; Law L; Grimard G; Deslandres C; Krupoves A; Bucionis V; Costea I; Bissonauth V; Feguery H; D'Souza S; Levy E; Seidman EG
    Am J Gastroenterol; 2008 Mar; 103(3):615-20. PubMed ID: 18047539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's disease.
    Doecke JD; Simms LA; Zhao ZZ; Roberts RL; Fowler EV; Croft A; Lin A; Huang N; Whiteman DC; Florin TH; Barclay ML; Merriman TR; Gearry RB; Montgomery GW; Radford-Smith GL
    J Gastroenterol Hepatol; 2015 Feb; 30(2):299-307. PubMed ID: 24989722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IL23R and ATG16L1 with susceptibility of Crohn's disease in Chinese population.
    Zhang J; Chen J; Gu J; Guo H; Chen W
    Scand J Gastroenterol; 2014 Oct; 49(10):1201-6. PubMed ID: 25048429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes.
    Lauriola M; Ugolini G; Rivetti S; Nanì S; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Belluzzi A; Castellani L; D'Uva G; Mattei G; Taffurelli M; Strippoli P; Solmi R
    Int J Mol Med; 2011 Mar; 27(3):469-77. PubMed ID: 21206965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.
    Csöngei V; Járomi L; Sáfrány E; Sipeky C; Magyari L; Faragó B; Bene J; Polgár N; Lakner L; Sarlós P; Varga M; Melegh B
    World J Gastroenterol; 2010 Jan; 16(2):176-83. PubMed ID: 20066736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the
    Borecki K; Zawada I; Salkić NN; Karakiewicz B; Adler G
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31052515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD2/CARD15 and IL23R genetic variability in 204 Algerian Crohn's disease.
    Meddour Y; Chaib S; Bousseloub A; Kaddache N; Kecili L; Gamar L; Nakkemouche M; Djidjik R; Abbadi MC; Charron D; Boucekkine TE; Tamouza R
    Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):499-504. PubMed ID: 24679666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.